Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease

Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease

Abstract Neurodegenerative diseases are a growing burden, and there is an urgent need for better biomarkers for diagnosis, prognosis, and treatment efficacy. Structural and functional brain alterations are reflected in the protein composition of cerebrospinal fluid (CSF). Alzheimer's disease (A...

Full description

Bibliographic Details
Main Authors: Jakob M Bader, Philipp E Geyer, Johannes B Müller, Maximilian T Strauss, Manja Koch, Frank Leypoldt, Peter Koertvelyessy, Daniel Bittner, Carola G Schipke, Enise I Incesoy, Oliver Peters, Nikolaus Deigendesch, Mikael Simons, Majken K Jensen, Henrik Zetterberg, Matthias Mann
Format: Article
Language:English
Published: Springer Nature 2020-06-01
Series:Molecular Systems Biology
Subjects:
Alzheimer's disease
cerebrospinal fluid
mass spectrometry
neurodegeneration
proteomics
Online Access:https://doi.org/10.15252/msb.20199356

Internet

https://doi.org/10.15252/msb.20199356

Similar Items